Table 1.
Characterization of CSR junctionsa
Study subjectsPerfectly matched short homologyNo. of junctions
0 bp
Direct end-joiningSmall insertions1–6 bp≥7 bp
Sµ-Sα      
ICF2-deficienta 4 (5)*↓ 11 (13)*↓ 34 (42) 33 (40)**↑ 82 
Lig4-deficientb 1 (3) 0 (0)**↓ 11 (37) 18 (60)****↑ 30 
Artemis-deficientc 0 (0)**↓ 6 (11)*↓ 18 (33) 30 (56)****↑ 54 
Controls (1–13 yr)d 34 (16) 52 (24) 77 (36) 50 (24) 213 
Sµ-Sγ      
ICF2-deficienta 9 (20) 3 (7) 34 (74) 0 (0) 46 
Lig4-deficientb 4 (12) 11 (32) 19 (56) 0 (0) 34 
Artemis-deficientc 5 (21) 4 (17) 15 (63) 0 (0) 24 
Controls (1–6 yr)e 13 (22) 9 (16) 36 (62) 0 (0) 58 
Study subjectsPerfectly matched short homologyNo. of junctions
0 bp
Direct end-joiningSmall insertions1–6 bp≥7 bp
Sµ-Sα      
ICF2-deficienta 4 (5)*↓ 11 (13)*↓ 34 (42) 33 (40)**↑ 82 
Lig4-deficientb 1 (3) 0 (0)**↓ 11 (37) 18 (60)****↑ 30 
Artemis-deficientc 0 (0)**↓ 6 (11)*↓ 18 (33) 30 (56)****↑ 54 
Controls (1–13 yr)d 34 (16) 52 (24) 77 (36) 50 (24) 213 
Sµ-Sγ      
ICF2-deficienta 9 (20) 3 (7) 34 (74) 0 (0) 46 
Lig4-deficientb 4 (12) 11 (32) 19 (56) 0 (0) 34 
Artemis-deficientc 5 (21) 4 (17) 15 (63) 0 (0) 24 
Controls (1–6 yr)e 13 (22) 9 (16) 36 (62) 0 (0) 58 

Data are n (%). Statistical analysis was performed by χ2 test. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.

a

The sequences of Sµ-Sα and Sµ-Sγ junctions are available in Data S1 and Data S2, respectively.

b

Previously published CSR junctions from Lig4-deficient patients (Pan-Hammarström et al., 2005).

c

Previously published CSR junctions from Artemis-deficient patients (Du et al., 2008).

d

Newly acquired and previously published Sµ-Sα junctions from children controls (Du et al., 2008; Enervald et al., 2013).

e

Previously published Sµ-Sγ junctions from children controls (Du et al., 2008).

or Create an Account

Close Modal
Close Modal